يعرض 161 - 180 نتائج من 41,616 نتيجة بحث عن '(( significant case based ) OR ( significant ((potential decrease) OR (substantial decrease)) ))', وقت الاستعلام: 1.83s تنقيح النتائج
  1. 161
  2. 162
  3. 163
  4. 164

    Deterministic result of the base-case analysis. حسب Sudewi Mukaromah Khoirunnisa (15288505)

    منشور في 2024
    "…Efficacy data and baseline characteristics in the base-case analysis were primarily derived from the 11-year results of the HERA trial. …"
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173

    The base case analysis. حسب Wenwang Lang (20293527)

    منشور في 2025
    "…</p><p>Results</p><p>In the base-case scenario, adding benmelstobart and anlotinib to chemotherapy increased QALYs by 0.34 at an additional cost of $24,684.07, yielding an ICER of $71,559.84 per QALY. …"
  14. 174
  15. 175

    Base-case results. حسب Shuo Kang (1306860)

    منشور في 2025
    "…One-way and probabilistic sensitivity analyses were conducted to estimate the robustness of the model results,</p><p>Results</p><p>In base-case analysis, compared with toripalimab plus chemotherapy and chemotherapy alone, ITH-testing directed therapy could bring additional 0.14 QALYs and 0.29 QALYs, with marginal costs of $3750.75 and $7778.18, resulting in the ICER of $27,353.27/QALY and $26,461.46/QALY, respectively, which lower than the Chinese willingness-to-pay (WTP) threshold. …"
  16. 176
  17. 177
  18. 178

    Base-case results. حسب Mingxi Xie (19812594)

    منشور في 2024
    "…The model time-frame was one-year. Base-case analysis and sensitivity analysis were performed. …"
  19. 179

    Base-case analysis. حسب Akiko Kowada (14659965)

    منشور في 2023
    "…The willingness-to-pay (WTP) threshold was set at US$50,000 per QALY gained. In the base-case analysis, HTLV-1 antenatal screening (US$76.85, 24.94766 QALYs, 24.94813 LYs, ICER; US$40,100 per QALY gained) was cost-effective compared with no screening (US$2.18, 24.94580 QALYs, 24.94807 LYs). …"
  20. 180